-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Pasithea Therapeutics Corp. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2021 to 2024.
- Pasithea Therapeutics Corp. Nonoperating Income (Expense) for the quarter ending December 31, 2024 was $81.9K, a 30.3% decline year-over-year.
- Pasithea Therapeutics Corp. Nonoperating Income (Expense) for the twelve months ending December 31, 2024 was $345K, a 26.8% decline year-over-year.
- Pasithea Therapeutics Corp. annual Nonoperating Income (Expense) for 2024 was $345K, a 26.8% decline from 2023.
- Pasithea Therapeutics Corp. annual Nonoperating Income (Expense) for 2023 was $472K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)